
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBCWWhmREJ0TGctZ0poV0wyM19rMWtMN09iNnZUZXFxQU9nVnlGcndpRGlWbTNkbFktbmZhOUpMcG1wdUtsSktVNzhQV0RISEpfWURlWWFWS3lBdG1yMWI0?oc=5" target="_blank">Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
